Tag: Absorb
TCT 2017: Advances in device technology needed to improve outcomes with Absorb
Data from the ABSORB ...
ACC 2017: Two-year rate of target lesion failure significantly higher with Absorb
Two-year data from th...
The implications of ABSORB II three-year results for the future of bioresorbable scaffolds
The idea of a fully b...
TCT 2016: Three-year data fail to show Absorb to be superior or even non-inferior to Xience
According to the thre...
Risk of device thrombosis may be significantly higher with Absorb than with Xience, Promus or Orsiro
A network meta-analys...
